Learn what Medicare and TRICARE cover

Jan. 23, 2024 Having trouble viewing this email? View it as a webpage. 4 Reminders About Getting Care With TRICARE For Life Medicare is your primary health coverage when you have TRICARE For Life. Knowing how Medicare coverage works can help you avoid unexpected costs. Read the article to learn more Don't forget to keep your family's information up to date in DEERS. Plans & Eligibility    Getting Care    What's Covered    Costs    Life Events    Forms & Claims SUBSCRIBER SERVICES Manage Preferences  |  Help

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: TRICARE Communications · 7700 Arlington Boulevard, Suite 5101 Falls Church, VA 22042-5101

---

Bidenomics Killing Retirement In America (It’s Only Going To Get Worse)

…You need to see this NOW!

Dear Reader, If you hope to have a comfortable retirement… You need to know the truth about what's really going on. Because Biden's economic agenda is… Destroying retirement for millions of Americans. Here are the facts: When Biden took office, the economy was cruising along just fine. Growing at a $1.5 trillion annualized rate. Inflation was just 1.4%. (Lower than the 2% target.) But 18 months later, under the Bidenomics agenda… Runaway inflation hit 40-year highs. Prices rose more in a month than the entire year before. With two consecutive quarters of economic contraction. (We used to call that a recession.) But the result was… Even worse for anyone hoping to retire any time soon. 401(k)accounts have lost 25% in real value. While pension plans are down a staggering $3.3 trillion in the last quarter of 2023. Not to mention that… The average American family has lost about $7,300 in annual income. Preventing many from putting away money for retirement. In a very real sense… Bidenomics is putting the brakes on retirement for millions. What can you do before it's too late? There is a simple solution. We explain it fully in our Ultimate Gold Investing Guide. Which reveals how to rollover your IRA, 401(k) or other qualifying retirement savings into gold and precious metals. This is a viable solution that will help you… Protect your retirement savings from economic crisis Safeguard your nest egg from a falling dollar before. AND grow your wealth despite what Washington is doing Claim your Free Copy of The Ultimate Gold Investing Guide today. Because time is of the essence. Click here now… Regards, Revelation Gold Group P.S. Along with your Free Guide, those who qualify can get up to $7,500 in Free Silver and a fireproof safe worth $400. To see if you qualify, click here to claim your Free Guide now. This third party offer is brought to you by Marketing Tech Solutions

Marketing Tech Solutions
T85, 5th Main Road, Anna Nagar, Chennai 600040, IN
© Copyright 2024. All Rights Reserved.

If you wish to stop receiving our emails or change your subscription options, please manage your subscription.

Can Some People with Breast Cancer Safely Skip Lymph Node Radiation? - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

Can Some People with Breast Cancer Safely Skip Lymph Node Radiation? 01/23/2024 Some people with no evidence of cancer in nearby lymph nodes after presurgical chemotherapy can skip radiation to that area without increasing the risk of the cancer returning, a clinical trial found. But some experts caution that more details are needed. You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

The ONLY Altcoin You Should Own

Juan Villaverde's Crypto Timing Model has nailed the big calls over and over again. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­

Dear Reader,

Juan Villaverde's Crypto Timing Model has nailed the big calls over and over again.

Like 1,135% on THORChain.

Or when he spotted Cardano at 4 cents … and watched it return 2,900%.

These aren't just cherry-picked winners.

The average gain on Juan's crypto recommendations is 328%. And that includes the losers.

Now, Juan says there is only ONE altcoin he recommends in the current market.

And he thinks it could be his next Cardano.

Click here to find out more about this special coin.

Regards,

Eliza Lasky
Weiss Advocate

 

Thank you for subscribing to Insider Trades Daily, which covers the most recent insider buying and selling activity from Wall Street CEO's, CFO's, COO's and other insiders.
 
This message is a paid advertisement sent on behalf of Weiss Ratings, a third-party advertiser of InsiderTrades.com and MarketBeat.
 
 

11780 US Highway 1,
Palm Beach Gardens, FL 33408-3080
Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list?
Copyright © 2023 Weiss Ratings. All rights reserved.

 
 
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you no longer wish to receive email from InsiderTrades.com, you can unsubscribe.
 
© 2006-2024 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.

 

Today's Bonus Content: New Trump Bombshell

A Very Special Invitation

Want to trade places with a multimillionaire? In short, this Thursday my friend Whitney Tilson is looking for "beta testers." He's confident he can show you how to make multiple times your money over the next 12 months... by "beta testing" a strategy you'd normally need $2 million to access.

Dear Reader, Want to trade places with a multimillionaire? In short, this Thursday my friend Whitney Tilson is looking for "beta testers." He's confident he can show you how to make multiple times your money over the next 12 months... by "beta testing" a strategy you'd normally need $2 million to access. It's a new way to see which stocks could double your money and beat the market with 91% accuracy, as he's already seen in backtests... using a strategy normally reserved for Wall Street insiders like him. Keep in mind: Whitney Tilson is a Wall Street legend who's been called "The Prophet" by CNBC. This Thursday, he's inviting you to try a breakthrough new investment system by essentially trading places with him. Five different billionaires have followed Whitney's work. He's a former $200 million hedge fund manager who tripled his clients' money and appeared on 60 Minutes twice, where he accurately called the 2008 housing collapse and the subsequent market rally... He predicted the 2017 bitcoin collapse to the day... Called the top of marijuana stocks to the hour on Yahoo Finance in 2018... The bottom of Netflix to the day in 2012 on CNBC, before it rose 90-fold... Along the way, he's met Presidents Obama, Clinton, Biden, and Warren Buffett. But today, Whitney is now opening the doors to a money-making strategy that – until now – has been almost entirely off-limits to all but the wealthiest hedge fund founders and their multimillionaire clients. This is a rare opportunity. By this Thursday, please give it your most serious consideration. Click here to learn more. Regards, Marc Chaikin Founder, Chaikin Analytics You are receiving this e-mail because you are a subscriber to Chaikin Analytics content. To unsubscribe from special offers like this one, click here to unsubscribe. Published by Chaikin Analytics, LLC. You're receiving this e-mail at edwardlorilla1986.paxforex@blogger.com. For questions about your account or to speak with customer service, call +1 (877) 697-6783 (U.S.), 9 a.m. - 5 p.m. Eastern time or e-mail info@chaikinanalytics.com. Please note: The law prohibits us from giving personalized financial advice. © 2024 Chaikin Analytics, LLC. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Chaikin Analytics, LLC. 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. www.chaikinanalytics.com.

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ A Message from The Oxford Club   |   Unsubscribe Dear Reader, In short, Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. In a Wall Street Journal interview this month, Dr. Lloyd Minor, dean of the Stanford University School of Medicine, said: "The drug discovery process is on the cusp of being transformed in ways that will dramatically improve the number of therapies that get to patients ... we'll see a lot of new medicines coming out - and medicines more specific to a disease and an individual rather than medicines that are generic in terms of treatment of everyone who has the disorder." Dr. Minor concludes that AI is "a transformative moment in human history," creating the most radical and "most positive transformation in health care since the introduction of antibiotics." This is going to dramatically alter medicine forever. Keep in mind, creating a new effective drug in the past took up to 10 years and could cost up to $12 billion. But now, with artificial intelligence, it could take months and cost a fraction of that amount. And there is one particular company at the forefront of all of this. It is the first company to bring an AI-designed drug to clinical trials. And as a result, Big Pharma is lining up to work with them. Merck is collaborating with them on three projects that could generate up to $674 million in revenue. French pharma giant Sanofi agreed to pay the company up to $5.2 billion to develop 15 new drugs. Bristol Meyers Squibb signed a $1.2 billion partnership with the company. And yet... the company I'm talking about is valued at just over $600 million today. And it trades for less than $10. In other words, these deals have the potential to drive the stock many times higher in the months and years ahead. If you're looking for a great AI stock to own,I invite you to watch my new presentation detailing the opportunity. Good investing, Alexander Green Cheif Investment Strategist, The Oxford Club

This message is a paid advertisement sent on behalf of The Oxford Club, a third-party advertiser of MarketBeat. Why did I receive this email?   If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   © 2006-2024 American Consumer News, LLC dba MarketBeat. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: New Trump Bombshell

It's time, Friend!

Today's class at 1pm ET with Fausto Pugliese is about to start, please join now...

Hi Friend, Today's class at 1pm ET with Fausto Pugliese is about to start, please join now... Click here to JOIN US LIVE now or enter https://ctu.co/join into your browser

JOIN LIVE CLASS NOW

Today's class will cover: Tape Reading Mastery: Unlock the power of interpreting order flow and market depth in real-time. Price Action Strategies: Learn to harness the significance of price movements for effective decision-making. Order Flow Dynamics: Explore the intricate dynamics of order flow and its impact on market movements. Advanced Level II, III, IV: Navigate the complexities of market depth with advanced level insights. Iceberg Orders: Demystify the secrets behind iceberg orders and how they shape market dynamics. Big Block Trades: Understand the nuances of large transactions and their influence on the broader market. About Fausto: Fausto Pugliese, the visionary behind Cyber Trading University and pioneer of one of the original day trading schools, boasts an illustrious 30+ year trading career by teaching his students the power of day trading. He stands as a trailblazer in the realm of independent trading, seizing the burgeoning Direct Access Trading technology wave in 1987. With an extensive reservoir of wisdom gleaned from hands-on experiences, Fausto commenced his journey at the grassroots, collaborating closely with some of the industry's most accomplished and proficient traders. After dedicating significant time to master the intricacies and discipline of day trading, Fausto embarked on the path of entrepreneurship, establishing his own company to impart his highly coveted insights. His expertise has graced the screens of renowned financial platforms, including Nasdaq TradeTalks, Fox News, and CNBC. Fausto's accolades further underscore his prowess, with numerous victories in international trading competitions against the industry's crème de la crème. Notably, he holds the title of 12-time champion at the esteemed World Traders Challenge. Moreover, Fausto is the esteemed author of "How To Beat Market Makers At Their Own Game – Uncovering the Mysteries of Day Trading," a publication within Wiley Trading's distinguished library. Don't miss out on this invaluable session! Join us on Zoom at 1:00 pm.

JOIN LIVE CLASS NOW

Cyber Trading University Education Department support@e.ctutrading.com (516) 280-5350 - Home www.cybertradinguniversity.com

Unsubscribe | CyberTradingUniversity.com is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. In addition, owners, employees, or representatives of Cyber Trading University are not investment advisors or registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. IMPORTANT NOTICE! No representation is being made that using this strategy or any trading methodology will be profitable. Past performance is not necessarily indicative of future results. There is substantial risk associated with equities trading of securities and options. Trading securities is not for everyone. Disclaimer: Day Trading, Swing trading, Stock Trading, Futures, Options, and Currency trading all have large potential rewards, but also large potential risk. You should be aware of the risks and accept them in order to invest in these markets. Do not trade with money you cannot afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures, options, or currencies. No representation or promise is being made that anyone is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading methodology is not necessarily a guarantee of future results. Visit our website below to read the full disclaimer. https://cybertradinguniversity.com/terms-of-use-disclosures/ Cyber Trading University 6800 Jericho Turnpike Suite 116W Syosset, New York 11791 United States (877) 702-9237